180 related articles for article (PubMed ID: 33475350)
1. ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models.
Li C; Kang L; Fan K; Ferreira CA; Becker KV; Huo N; Liu H; Yang Y; Engle JW; Wang R; Xu X; Jiang D; Cai W
Bioconjug Chem; 2021 Jul; 32(7):1306-1314. PubMed ID: 33475350
[TBL] [Abstract][Full Text] [Related]
2. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
[TBL] [Abstract][Full Text] [Related]
3. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.
Sun H; England CG; Hernandez R; Graves SA; Majewski RL; Kamkaew A; Jiang D; Barnhart TE; Yang Y; Cai W
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2169-2179. PubMed ID: 27342417
[TBL] [Abstract][Full Text] [Related]
4. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
5. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors.
Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W
Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694
[TBL] [Abstract][Full Text] [Related]
6. ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model.
Ferreira CA; Hernandez R; Yang Y; Valdovinos HF; Engle JW; Cai W
Mol Pharm; 2018 Aug; 15(8):3434-3441. PubMed ID: 29889530
[TBL] [Abstract][Full Text] [Related]
7. ImmunoPET of the differential expression of CD146 in breast cancer.
Ferreira CA; Kang L; Li C; Kamkaew A; Barrett KE; Aluicio-Sarduy E; Yang Y; Engle JW; Jiang D; Cai W
Am J Cancer Res; 2021; 11(4):1586-1599. PubMed ID: 33948375
[TBL] [Abstract][Full Text] [Related]
8. Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
Yang Y; Hernandez R; Rao J; Yin L; Qu Y; Wu J; England CG; Graves SA; Lewis CM; Wang P; Meyerand ME; Nickles RJ; Bian XW; Cai W
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6525-34. PubMed ID: 26553993
[TBL] [Abstract][Full Text] [Related]
9.
Kwon LY; Scollard DA; Reilly RM
Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
[TBL] [Abstract][Full Text] [Related]
10. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
[TBL] [Abstract][Full Text] [Related]
11. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.
Luo H; Hong H; Slater MR; Graves SA; Shi S; Yang Y; Nickles RJ; Fan F; Cai W
J Nucl Med; 2015 May; 56(5):758-63. PubMed ID: 25840981
[TBL] [Abstract][Full Text] [Related]
12. CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma.
Wei W; Jiang D; Ehlerding EB; Barnhart TE; Yang Y; Engle JW; Luo QY; Huang P; Cai W
Adv Sci (Weinh); 2019 May; 6(9):1801237. PubMed ID: 31065511
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and Preliminary Evaluation of Dual Target PET Probe [18F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer.
Chen Z; Fu H; Wu H; Huang J; Yao L; Zhang X; Li Y
Anticancer Agents Med Chem; 2020; 20(13):1548-1557. PubMed ID: 32329699
[TBL] [Abstract][Full Text] [Related]
14. Bio-functionalized dense-silica nanoparticles for MR/NIRF imaging of CD146 in gastric cancer.
Wang P; Qu Y; Li C; Yin L; Shen C; Chen W; Yang S; Bian X; Fang D
Int J Nanomedicine; 2015; 10():749-63. PubMed ID: 25653520
[TBL] [Abstract][Full Text] [Related]
15. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
16. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
Liu Z; Yan Y; Liu S; Wang F; Chen X
Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
[TBL] [Abstract][Full Text] [Related]
17. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive PET imaging of tumor PD-L1 expression with
Malih S; Lin W; Tang Z; DeLuca MC; Engle JW; Alirezapour B; Cai W; Rasaee MJ
Am J Nucl Med Mol Imaging; 2024; 14(1):31-40. PubMed ID: 38500749
[TBL] [Abstract][Full Text] [Related]
19. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.
Hong H; Yan Y; Shi S; Graves SA; Krasteva LK; Nickles RJ; Yang M; Cai W
Mol Pharm; 2015 Feb; 12(2):403-10. PubMed ID: 25581441
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
